S3323-119

In Committee

Family Vaccine Protection Act

119th Congress Introduced Dec 3, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

Codifies the Advisory Committee on Immunization Practices and sets evidence, publication, timing, and review rules for vaccine recommendations.

Who Benefits and How

Vaccine manufacturers, providers, insurers, and patients gain a more formal and time-bound recommendation process for new vaccines, while vaccine coverage and VFC decisions become more tightly linked to a codified framework.

Who Bears the Burden and How

CDC and HHS leaders face new publication, explanation, notification, timing, and evidence-review obligations when handling ACIP recommendations.

Key Provisions

  • Creates a statutory ACIP section and subjects the committee to most Federal Advisory Committee Act requirements.
  • Requires CDC leadership to adopt or publicly justify non-adoption of ACIP recommendations based on peer-reviewed evidence.
  • Sets timing rules for new vaccine consideration and codifies ACIP roles in coverage recommendations and the Vaccines for Children Program.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

Codifies the Advisory Committee on Immunization Practices and sets evidence, publication, timing, and review rules for vaccine recommendations.

Key Policy Areas

Healthcare, Government Operations

Primary Purpose

Codifies the Advisory Committee on Immunization Practices and sets evidence, publication, timing, and review rules for vaccine recommendations.

Policy Domains

Healthcare Government Operations

Main Provisions

Identified Gains
Contextual inference, no direct clause citation
  • Vaccine developers seeking predictable recommendation review
  • Patients and providers relying on vaccine recommendation clarity
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • CDC and HHS decision-makers
  • Advisory Committee on Immunization Practices administrators
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is

Contextual inference, no direct clause citation

Legislative Progress

In Committee
Introduced Committee Passed
Mar 19, 2026

Committee on Health, Education, Labor, and Pensions. Hearings held.

Dec 3, 2025

Mr. Hickenlooper (for himself, Mr. Markey, Ms. Blunt Rochester, Mr. …

Dec 3, 2025

Read twice and referred to the Committee on Health, Education, …

Dec 3, 2025

Introduced in Senate

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
2 mentions across 2 clauses
-2 negative

CDC and HHS vaccine recommendation administrators

Healthcare
2 mentions across 2 clauses
+2 positive

Vaccine manufacturers seeking ACIP review

2/4
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Government Operations
Actor Mappings
"the director"
→ Director of the Centers for Disease Control and Prevention
"the secretary"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology